key: cord-0683063-jx9g8c3q
authors: Graciaa, Daniel S.; Kempker, Russell R.; (Wayne) Wang, Yun F.; Schurr, Hanna; Krishnan, Snehaa D.; Carroll, Kelley; Toomer, Linda; Merritt, Stephanie; King, Denise; Hunter, Mary; Rebolledo, Paulina A.
title: SARS-CoV-2 seroprevalence among healthcare personnel at a large health system in Atlanta: SARS-CoV-2 among healthcare personnel in Atlanta
date: 2022-04-14
journal: Am J Med Sci
DOI: 10.1016/j.amjms.2022.04.009
sha: 97d4b38fe63257af516a60cba959a897ef8d8f99
doc_id: 683063
cord_uid: jx9g8c3q

BACKGROUND: : Estimates of the prevalence of SARS-CoV-2 antibodies and factors associated with infection among healthcare personnel (HCP) vary widely. We conducted a serosurvey of HCP at a large public healthcare system in the Atlanta area. METHODS: : All employees of Grady Health System were invited to participate in mid-2020; a volunteer sample of those completing testing was included. Asymptomatic HCP were offered testing for IgG antibody and for SARS-CoV-2 RNA using polymerase chain reaction (PCR). Symptomatic HCP were offered PCR testing. Antibody index values for IgG and cycle threshold values for PCR were evaluated for those with a positive result. An online survey was distributed at the time of testing. RESULTS: : 624 of 1677 distributed surveys (37.2%) were completed by 608 unique HCP. The majority were female (76.4%) and provided clinical care (70.9%). The most common occupations were clinician (24.8%) and nurse (23.5%). 37 of 608 (6.1%) HCP had detectable IgG. Exposure to a confirmed case of COVID-19 outside of the hospital was associated with detectable IgG (12.8% vs 4.4%, p=0.02), but exposure to a patient with COVID-19 was not. CONCLUSIONS: : Among HCP in a large healthcare system, 6.1% had detectable SARS-CoV-2 IgG. Seropositivity was associated with exposures outside of the healthcare setting.

Since emerging in late 2019, the novel coronavirus SARS-CoV-2 has caused a global pandemic of coronavirus disease 2019 , with the United States now accounting for the highest number of reported cases and deaths. 1 Preventing nosocomial spread of COVID-19 is essential to protect healthcare personnel (HCP), who are at high risk of infection due to frequent exposure, and thousands of whom have died of COVID-19. 2, 3 This requires a better understanding of COVID-19 transmission in healthcare facilities, particularly the role of asymptomatic transmission and exposures both in and out of the workplace. Despite the availability of highly effective SARS-CoV-2 vaccines, not all HCP have been or will be immunized, and post-vaccination illness can occur. [4] [5] [6] Infection control measures and testing will remain essential for preventing transmission among HCP and between HCP and patients.

Medical center testing programs have found that a minority of HCP with anti-SARS-CoV-2 antibodies reported symptoms consistent with COVID-19 illness or thought that they were previously infected with COVID-19, but asymptomatic carriage remains a concern. 7,8 These findings suggest that testing only symptomatic HCP may miss a sizeable proportion of SARS-CoV-2 cases among this population. Studies of SARS-CoV-2 antibody seroprevalence among HCP have produced a range of estimates and illustrated the importance of preventive measures. In a multi-site study, approximately 6% of HCP were seropositive, but 29% of these HCP had been asymptomatic, and 44% did not believe they previously had COVID-19. 9 Prevalence of SARS-CoV-2 antibodies was higher among those who did not report always wearing a facial covering. 5 In a large health care system, implementation of a mask requirement in hospitals was associated with a decrease in SARS-CoV-2 PCR positivity from 14.7% to 11.5%, suggesting universal face coverings may reduce the spread of COVID-19 in the hospital setting. 10 Provided adequate preventive measures in healthcare facilities, exposure to SARS-CoV-2 outside of the healthcare workplace takes on greater importance. In hospital-wide antibody screening in Belgium, the odds of seropositivity were not increased by having direct involvement in clinical care nor working in COVID-19 wards, but were increased with contact with a suspected COVID-19 case within the household. 11 In another study, known exposure to COVID-19 outside of the hospital was associated with 14.8% seroprevalence compared to 3.7% among those with no exposure outside the hospital. 12 We have previously reported results of a program testing symptomatic HCP at Grady Health System (GHS), a large public healthcare system in Atlanta 13 In this subsequent study, all GHS employees were invited to participate in a testing program involving SARS-CoV-2 serology, PCR, and a questionnaire to describe the seroprevalence and factors associated with SARS-CoV-2 infection among HCP.

The Grady Health System COVID-19 screening program used re-deployed hospital staff and was implemented through employee health services. The program was voluntary and was advertised through institutional emails to hospital employees and medical staff. All employees 6 were eligible to be tested regardless of position or symptoms. Asymptomatic HCP were scheduled for both IgG and PCR testing for SARS-CoV-2, while symptomatic HCP were offered PCR. Testing was conducted Monday through Friday in an outdoor medical tent located near the emergency department. A rotating team of GHS-employed nurses and medical assistants conducted tests using blood draws and nasopharyngeal swabs. From May 11 through July 20, 2020, an online REDCap survey was distributed to HCP electronically prior to testing to collect demographic information, COVID-19 exposures, and SARS-CoV-2 testing history with questions based on the World Health Organization risk assessment tool (Supplementary data). 14, 15 Exposure was defined as self-reported interaction with a personal contact or patient with confirmed COVID-19. SARS-CoV-2 IgG serology testing was conducted using the Abbott Architect instrument (Abbott Park, IL) using the Abbott SARS-CoV-2 IgG nucleocapsid assay and SARS-CoV-2 polymerase chain reaction (PCR) testing was conducted using the Abbott Laboratories 

A total of 1677 HCP were invited to participate. 624 (37.2%) surveys were completed by 608 unique HCP (Fig 1) . The median age of these HCP was 41 years (IQR 31-50), and the majority were female (76.4%), worked at Grady Memorial Hospital (77.8%), and provided clinical care to patients (70.9%) ( Table 1 ). The most common occupations were nurse (23.5%) and clinician (24.8%), which included physicians, nurse practitioners, and physician assistants.

Overall, 1412 HCP were tested for SARS-CoV-2 antibodies during the study period and 91 (6.4%, 95% CI 5.3-7.8%) had detectable IgG. Of the 608 unique HCP who completed surveys, 37 (6.1%, 95% CI 4.3-8.3%) had detectable SARS-CoV-2 IgG. Among the surveyed HCP, seropositivity was more common among males than females (11.2% and 4.5%, respectively, p=0.03), but other demographic characteristics including body mass index, self-reported medical conditions, 8 primary work location, and occupation did not significantly differ by serostatus. Among the 37 HCP with an initial positive antibody, 6 had subsequent antibody testing at a median of 46 days (IQR 34-57), and all remained IgG positive. Among the 571 with an initial negative antibody, 56 had subsequent antibody testing at a median of 49 days (IQR 35.5-57), and only 2 had seroconverted.

Overall, HCP who reported exposure to a confirmed case of COVID-19 outside of the hospital (14.1%) were more likely to be seropositive compared to those without such exposure (12.8% and 4.4%, respectively, p=0.02), while there was no difference in seropositivity between those who reported exposure to a patient with COVID-19 and those who did not. After excluding those who self-reported a prior known positive nasal or oral swab test for SARS-CoV-2, believing one previously had COVID-19 disease was more common among those who were seropositive (p<0.0001) (Fig 2) . However, of the 92 HCP in this subgroup who believed they had COVID-19, the majority (64, 69.6%) were seronegative. Of the 24 who were seropositive, 9

(37.5%) did not believe they had previously been infected.

Clinical care, PPE, and procedures 9 Of the 431 HCP who reported providing clinical care to patients, most (83.8%) spent >4 hours per day doing so. The most common care areas were outpatient (31.6%), medical/surgical floors (22.5%), intensive care units (18.6%), and emergency department (13.7%), and there was no association between seropositivity and working in these areas. A small proportion (18.6%) were present during aerosol-generating procedures for a patient with confirmed or suspected COVID-19; the most common procedures were intubation (15.1%), airway suctioning (10.7%), and cardiopulmonary resuscitation (6.3%). Among those who reported face to face contact with a confirmed case, nearly all HCP (78.6%) reported always wearing PPE. There was no association between aerosol-generating procedures or self-reported PPE use and SARS-CoV-2 IgG.

A total of 535 HCP had SARS-CoV-2 PCR results, with 20 positive (3.7%, 95% CI 2.3-5.7%).

There was no association between PCR positivity and demographic characteristics (Table 1) . A positive PCR result was more likely in HCP who were present for aerosol-generating procedures in general (7.5 vs 1.4%, p<0.01) and intubation in particular (7.7 vs 1.6%, p=0.01) than those who were not. To examine self-reported symptoms, results were limited to HCP who responded to the survey within 7 days of a PCR result. Of the 10 HCP in this group with a positive PCR, 3 (30%) were symptomatic in the previous 14 days; PCR positivity was not more common among those with any symptoms or individual symptoms (Supplemental table) . Notably, of the 435 HCP who were asymptomatic, 7 (1.6%) had SARS-CoV-2 detected by PCR.

For those HCP who were either SARS-CoV-2 IgG or PCR positive, antibody index and CT values were not correlated. There was no significant difference in index or CT values by belief one had previous COVID-19, exposure to family or friends with confirmed COVID-19, or presence for aerosol-generating procedures ( Table 2 ). The median index value was higher for those who reported recent symptoms (6.75, IQR 4.75-6.92) compared to those who were asymptomatic (4.62, IQR 2.86-6.25), but this difference was not statistically significant. Among 

We screened 608 healthcare personnel at a large public healthcare system for SARS-CoV-2 IgG from May to July 2020 and found that 37 (6.1%) had detectable antibodies. HCP who believed they previously had COVID-19 and those who had exposure to a confirmed case 11 among family or friends were more likely to be seropositive. The estimated seroprevalence is consistent with that reported in the literature, including a large study of 3,248 HCP in 13 academic medical centers which found approximately 6% had SARS-CoV-2 antibodies, with seroprevalence by hospital ranging from 0.8% to 31.2%. 9,16,17 A serosurvey of another large healthcare system in the Atlanta area during a similar time period (April to June 2020) estimated a slightly lower crude (5.7%) and adjusted (3.8%) seroprevalence than our study, but similarly determined community risk factors were better associated with seropositivity than workplace exposures. 18 Notably, these estimates are higher than the estimated community seroprevalence in the two counties served by our healthcare system in the weeks prior to the study period (2.5%, 95% CI 1.4-4.5%). 19 Evaluating seropositivity among HCP remains important, as there is a significantly reduced risk of reinfection over 6 months in those with IgG antibodies, and vaccine implementation is ongoing. 20 Our study population included those in both clinical care and non-patient-facing roles, but seropositivity was not associated with occupation, patient care, PPE use, or presence during aerosol generating procedures. These findings support recent data indicating hospital infection control measures have reduced the risk of SARS-CoV-2 infection for HCP within the healthcare environment but that exposure away from the workplace is an important ongoing risk factor. [10] [11] [12] Importantly, among HCP in our study without a known prior positive test who believed they had COVID-19, the majority (70%) were seronegative and of those who were seropositive, more than a third did not believe they had previously been infected. In this general screening 12 program, 3.7% of HCP with PCR testing had SARS-CoV-2 detected, including 1.6% of those who were asymptomatic at the time of testing. While the association of PCR positivity with aerosolgenerating procedures likely reflects the changing PPE recommendations early in the pandemic and underscores the need for adherence to infection control measures, the presence of asymptomatic infection and the unreliability of self-diagnosis have implications for staff screening and monitoring programs. 21 Although three COVID-19 vaccines have received emergency use authorization from the Food and Drug Administration, healthcare systems will likely continue to require that HCP reduce their risk of exposure to SARS-CoV-2 and self-monitor for symptoms until more widespread distribution of vaccines and while variants of concern emerge, particularly as outbreaks in hospital settings have been associated with unmasked exposure among HCP. 22 We found no correlation between antibody index and CT values for those HCP who were either IgG or PCR positive, and no association between these quantitative results and HCP characteristics or exposures. Notably, median CT values were similar between symptomatic and asymptomatic HCP with SARS-CoV-2 detected by PCR, which is consistent with previous findings of similar viral load in symptomatic and asymptomatic infection. 23 However, there were relatively few PCR-positives and results could be affected by prolonged PCR positivity. Others have shown that among HCP with COVID-19 illness, symptomatic individuals had higher antibody index than those who were asymptomatic. 24 Our data are similar, though the lack of a 13 significant difference may be due to sample size or differences in symptom assessment at initial scheduling and survey distribution. Among HCP at a large urban healthcare system screened for SARS-CoV-2 early in the pandemic, 6.1% had detectable IgG, seropositivity was associated with exposures outside of the healthcare setting, and more than a third of seropositive HCP did not believe they had previously been infected. Even with the implementation of effective infection prevention measures within hospitals and clinics, maintaining focus on minimizing the risk of exposure both at work and home is critical to protect healthcare personnel and patients as the COVID-19 pandemic continues to impact communities and healthcare systems. The authors report no conflicts of interest. 

An interactive web-based dashboard to track COVID-19 in real time

Guardian/KHN find nearly 3,000 US health workers died of Covid. The Guardian

Healthcare worker infections and deaths due to COVID-19: A survey from 37 nations and a call for WHO to post national data on their website

Impact of coronavirus disease 2019 (COVID-19) vaccination program on healthcare worker infections in an academic hospital

Coronavirus disease 2019 (COVID-19) vaccination in healthcare workers: An early real-world experience

Postvaccination COVID-19 among Healthcare Workers

Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for COVID-19 Patients

Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission

Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network -13 Academic Medical Centers

Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers

Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center

Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection among Veterans Affairs healthcare system employees suggests higher risk of infection when exposed to SARS-CoV-2 outside the work environment

Loss of Smell and Taste Among Healthcare Personnel Screened for Coronavirus

The REDCap consortium: Building an international community of software platform partners

Risk assessment and management of exposure of health care workers in the context of COVID-19

Healthcare worker seroconversion for SARS-CoV-2 at two large health systems in San Diego

Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center

Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System

Estimated Community Seroprevalence of SARS-CoV-2 Antibodies -Two Georgia Counties

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

COVID-19 symptoms and SARS-CoV-2 antibody positivity in a large survey of first responders and healthcare personnel

Hospital-Acquired SARS-CoV-2 Infection: Lessons for Public Health

Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review

SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study

SARS-CoV-2 seroprevalence and antibody kinetics among health care workers in a Spanish hospital after three months of followup

PCR = polymerase chain reaction. IQR = interquartile range

The authors thank the Grady HCP COVID-19 Screening Team, including Catherine Abrams, Starr Toliver, Meredith Cherry, and Marilyn McCain.